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Abstract 
Fullerenol (C60(OH)24) nanoparticles (FNP) have a significant role in biomedical research
due to their numerous biological activities, some of which have cytoprotective and anti-
oxidative properties. The aim of this study was to measure distribution of fullerenol nano-
particles and zeta potential in cell medium RPMI 1640 with 10% fetal bovine serum (FBS)
and to investigate the influence of FNP on Chinese hamster ovary cells (CHO-K1) survival, 
as well as to determine the activity of three antioxidative enzymes: superoxide-dismutase, 
glutathione-reductase and glutathione-S-transferase in mitomycin C-treated cell line. Our 
investigation implies that FNP, as a strong antioxidant, influences the cellular redox state 
and enzyme activities and thus may reduce cell proliferation, which confirms that FNP
could be exploited for its use as a cytoprotective agent. 
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With the rapid development of nanotechnology, 
many kinds of nanomaterials have been and are being 
used in fields of industry and scientific researches. A 
wide range of engineered nanoparticles, ranging from 
1–100 nm, have been proposed to be used in nano-
medicine due to their unique physical and chemical 
characteristics. Fullerenols are polyhydroxylated fuller-
enes C60(OH)x (between 2 > x < 44). Fullerenol C60(OH)24 
has a diameter of approximately 1 nm with symmet-
rically arranged hydroxyl groups on the C60 sphere [1]. 
Fullerenol dissolved in water forms polyanion nanopar-
ticles of size mostly between 3 and 100 nm [2,3]. 
Polyhydroxylated fullerenes, including C60(OH)24, have 
demonstrated high antioxidative activity in many chem-
ical, in vivo and in vitro studies [4–7]. Mrdjanovic et al. 
confirmed the antigenotoxic effect of FNP on mito-
mycin-damaged CHO-K1 cells [8]. In vitro and in vivo 
studies have proved fullerenol’s tissue-protective effect 
in irradiated human erythroleukemia cell line K562 and 
organs of rats, due to its antioxidative and radical 
scavenging activity [9,10]. Results of studies on healthy 
and tumor-bearing rats, treated with a single high dose 
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of doxorubicin (DOX), imply the potential tissue-pro-
tective role of FNP [11–18]. 
Internalization of nanoparticles into live cells is 
closely related to their potential application, function 
and cytotoxicity. It is known that cellular uptake and 
the processes of cellular delivery are influenced by 
various factors, such as: physicochemical properties of 
nanoparticles (chemical composition, size, shape and 
surface charge), concentration of nanoparticles, incub-
ation time, the type of cells, etc. [19]. 
Mitomycin C (MMC) is an antitumor quinone that 
undergoes reductive metabolism to generate reactive 
electrophilic species, which can then alkylate cellular 
nucleophiles. It also acts as a DNA cross-linking agent 
[20]. 
The aim of this study was to measure distribution of 
FNP by volume and number, as well as zeta potential of 
particles, in aqueous solution and in RPMI 1640 with 
10% FBS in dark on 37 °C during 24 h, which are basic-
ally used to treat the particles in cell culture. Based on 
the above mentioned fact concerning numerous bio-
logical activities of FNP, our additional goal was to test 
in vitro influence of FNP on cell's survival and activity of 
three antioxidative enzymes: total superoxide-dismut-
ase (SOD), glutathione–reductase (GR) and glutathione- 
-S-transferase (GST), in both, mitomycin C-treated CHO- 
-K1 cells and control untreated groups of CHO-K1 cell 
line. 
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MATERIALS AND METHODS 
Fullerenol nanoparticle synthesis 
Fullerenol C60(OH)24 was synthesized in alkaline 
media by complete substitution of bromine atoms from 
C60Br24. Briefly, the polybromine derivative C60Br24 was 
synthesized through catalytical (FeBr3) reaction of C60 in 
Br2 [21]. 50 mg of C60Br24 was mixed in 5ml of NaOH pH 
10 for 2 h at room temperature. After the reaction was 
completed, the solvent was evaporated at 40 °C, and 
the mixture was rinsed five times with 10 ml portions 
of 80% ethanol. The aqueous solution of fullerenol (20 
ml) with residual amounts of NaOH and NaBr was 
applied on the top of the combined ion-exchange resin 
DOWEX MB50 QC121815 R1 (20 g) and eluted with 
demineralized water until discoloration. The solution of 
fullerenol (pH 7) was evaporated under low pressure; a 
dark brown powder substance remained. Analysis: FTIR 
C60(OH)24: 3427, 1627, 1419, 1080 cm–1; 13C-NMR (D2O) 
reaction mixture: singlet peaks at δ 77.7 ppm and mul-
tiplet at δ 140 ppm, 13C-NMR (D2O) C60(OH)24: singlet 
peaks δ 169.47 ppm and multiplet peak δ 160–110 
ppm; MALDI (matrix α-cyano-4-hydroxycinnamic acid) 
(m/z): 720 (C60+), 721 (C60H+), 722 (C60H2+), 737 
(C60(OH)+), 808 (C60(OH)5+), 839 (C60(OH)7+), 856 
(C60(OH)8+), 1009 (C60(OH)17+), 1026 (C60(OH)18+) and 
minor peak 1128 (C60(OH)24+); DTG, DTA, TG reveal two 
thermal changes, in temperature of 120–395 °C, cor-
responding to the loss of mass of 35.7% (23.7 OH 
groups) and at the temperature of 430 °C loss of mass 
was 64.3% (this was the temperature of sublimation of 
C60). Elementary analysis of fullerenol provided the fol-
lowing: C, 63.00%; H, 2.00% calc.: C, 63.83%; H, 2.13%. 
Size distribution of nanoparticles 
In order to obtain results for distribution of particles 
by volume and number, as well as zeta potential of par-
ticles, high performance analyzer Zetasizer Nano ZS 
(Malvern Instruments) was used. Prior to measure-
ment, samples were tempered at 37 °C for 24 h and 
stored in the dark. 
Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) was performed 
with a JEOL JSM 6460 LV scanning microscope (300000× 
magnification). The 10 ppm aqueous solution of fulle-
renol was placed on a conductive carbon tape, evapor-
ated under reduced pressure and covered with a thin 
gold layer about 5 nm. 
Cell line treatment 
All the experiments were performed on Chinese 
hamster ovary cell line CHO-K1, ATCC CCL61 (American 
Type Culture Collection Catalogue of Cell Lines and 
Hybridomas, 6th ed., 1988). CHO-K1 cells were cultured 
as a tightly flask-bonded monolayer in RPMI 1640 med-
ium (Sigma), supplemented with 10% FCS (Veterinary 
institute Novi Sad, NIVNS), 2 mM L-glutamine, penicillin 
(100 IJ/mL) and streptomycin (100 µg/mL, Galenika) at 
37 °C in fully humified atmosphere with 5% CO2. Single- 
-cell suspension was obtained with 0.25% trypsin or 
trypsin in EDTA (Sigma). Cells were passaged twice a 
week in concentration of 50000–100000 cells/ml. 
CHO-K1 sample cells were plated in sterile culti-
vation plates (Costar, 6 well) in concentration of 
200000/ml and treated as follows:  
Control – untreated cells 
MMC – mitomycin C 0.1 μg/ml 
F1 – FNP 0.025 mg/ml 
F3 – FNP 0.125 mg/ml 
F1 + MMC – FNP 0.025 mg/ml 30 min before MMC 
0.1 μg/ml 
F3 + MMC – FNP 0.125 mg/ml 30 min before MMC 
0.1 μg/ml. 
FNP was dissolved in bi-distilled water and added in 
the cell culture in two final concentrations: 0.025 and 
0.125 mg/ml in a 3- and 24-hour treatment. 
Mitomycin C was dissolved in distilled water and 
added in cell culture samples in final concentration of 
0.1 μg/ml in a 3- and 24-hour treatment. 
In FNP pretreated samples, FNP was added half an 
hour before MMC. 
Dye exclusion test (DET) with Trypan blue was used 
to monitor the cell survival [22]. The DET test was 
performed by mixing 50 μl of cell suspension with 200 
μl of 0.1% Trypan blue solution in 0.9% NaCl. After 2 
min of incubation at a room temperature, the number 
of viable cells (unstained cells) was determined using a 
Burker-Turk hemocytometer. 
Survival rate was calculated according to formula:  
Survival rate (%) = 100×(Total number of viable cells in 
experimental group / Total number of viable cells in 
control group) 
All enzyme activity assays were performed in cyto-
solic cell fraction, in supernatant obtained by 
ultrasonication (Soniprep 150 MSE) (10 min at 10000 
rpm at 4 °C) and kept at –80 °C. All spectrophotometric 
measurements were carried out in triplicates (Agilent 
8453 UV/Vis spectrophotometer with thermostatted 
multicell position sample system).  
Superoxide dismutase assay 
Total (Cu–Zn and Mn) superoxide dismutase (SOD) 
activity measuring method was based on the ability of 
superoxide dismutase to inhibit the auto-oxidation of 
epinephrine [23]. One unit of activity was defined as 
the amount of enzyme necessary to decrease by 50% 
the rate of adrenalin auto-oxidation at pH 10.2 and 480 
nm. The results were expressed as U/106 of cells.  
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Glutathione reductase assay 
Glutathione reductase (GR) was determined mea-
suring the reduction rate of oxidized glutathione with 
NADPH as suitable enzyme substrate at 340 nm [24]. 
Activity of GR was defined as nmol of NADPH/min per 
106 of cells. 
Glutathione-S-transferase assay 
Glutathione-S-transferase (GST) was based on con-
jugation of –SH group of reduced glutathione with 
1-chloro-2,4-dinitrobenzene (CDNB) [24]. Absorbance 
of the conjugate CDNB–glutathione was measured at 
340 nm. Activity of GST was expressed as nmol of 
CDNB-glutathione conjugate/min per 106 of cells.  
Statistical analysis 
The data were analyzed by Multivariate analysis of 
variance (MANOVA) followed by Duncan test at 0.05 
significance level to compare the means using SPSS 
13.0 for Windows. 
RESULTS AND DISCUSSION 
Results for size distribution of particles by volume 
(Fig. 1a) put an emphasis on inhomogeneity of the 
analyzed samples. In all samples can be noticed the 
presence of particles of dimensions within 2–30 nm, 
with the maximum at 5 nm. Fullerenol nanoparticles in 
aqueous solution are mostly within 2–8 nm, while in 
samples containing fetal bovine serum size varies 
within 2–30 nm. Addition of FNP in the cell culture 
medium with 10% FBS has not influenced the size dis-
tribution of nanoparticles by volume. 
Figure 1b presents nanoparticle’s size distribution 
by number in which particles are classified into a family 
within 2–9 nm, with the maximum at approx. 5 nm. It 
can be concluded that addition of FNP in the culture 
medium with 10% FBS has not induced changes in the 
size of particles. 
In Figure 2, SEM image of the fullerenol nano-
particles studied in this work shows the particles size 
from 30–80 nm. These findings are in accordance with 
DLS and AFM measurements conducted before [25].  
 
Figure 2. SEM image of film resulted from a 10 ppm aqueous 
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Figure 1. Size distribution of nanoparticles a) by volume and b) by number, in the following samples: cell culture medium RPMI 1640 
+ 10% FBS (green); aqueous solution of fullerenol (red); and fullerenol in cell culture medium RPMI 1640 + 10% FBS (blue), after 
incubation for 24 h at 37 °C in the dark. 
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Table 1 shows the results of measurements for 
ζ-potential of the following systems: RPMI 1640 + 10% 
FBS, aqueous solution of FNP pH 6, and aqueous sol-
ution of FNP in RPMI + 10% FBS (incubated for 24 h at 
37 °C in the dark). ζ-potential of polyanionic fullerenol 
nanoparticles at pH 6 is –58 mV. After addition of FNP 
in the cell culture medium RPMI with 10% FBS, ζ-pot-
ential of the medium slightly changed from –3.6 to –7.9 
mV; ζ-potential of nanoparticles solution changed from 
–58 to –7.9 mV. 
Table 1. ζ-potential of the following systems: RPMI 1640 + 
10% FBS, aqueous solution of FNP and aqueous solution of 
FNP in RPMI + 10% FBS (incubated for 24h at 37 °C in the 
dark) 
Sample ζ-potential, mV 
RPMI 1640 + 10% FBS –3.6 
Aqueous solution of FNP: FNPaq, pH 6 –58 
FNPaq + RPMI + 10% FBS –7.9 
It has been confirmed that particles’ size has an 
important role on their adhesion to and interaction 
with biological cells. It is also known that the size of 
FNP is an important property in the toxicity analysis, 
since nanoparticles have a tendency to form agglo-
merates, which may behave differently from a single 
nanoparticle. Also, the presence of proteins in the cul-
ture medium can change the nanoparticles agglomer-
ation and influence the cellular response. Nanopar-
ticles, which are partially covered by proteins in body 
fluids, can change reactivity, charge and hydrophobicity 
[26]. It is also well-known that FNP can pass through 
the plasma membrane and manifest its biological 
effects inside the cell [27]. 
We can conclude that investigated FNP does not 
have a tendency to form agglomerates, based on the 
results for distribution of particles by volume and 
number obtained in our experiment, as well as accord-
ing to the measurements for ζ-potential after incub-
ation in cell medium. Furthermore, the presence of 
proteins in the culture medium does not induce sig-
nificant changes in terms of nanoparticles agglomer-
ation. Results of AFM analysis of FNP in the cell culture 
medium supplemented with 20% of FBS [25] revealed 
that FNP (which in water form aggregates of approx. 90 
nm) forms a stable and homogenous solution that 
mostly consists of two dimer particles of 90 nm asso-
ciated with one smaller nanoparticle of about 40 nm, 
which was assumed to be a protein from the FBS. 
Results obtained in our experiment show that addi-
tion of FNP in the cell culture medium with 10% FBS 
does not influence the size distribution of nanoparticles 
and does not induce formation of such a large particle, 
but causes reduction in ζ-potential of nanoparticles 
(from –58 to –7.9 mV). Monitoring of ζ-potential is 
particularly important due to possible interactions that 
can be favored as a result of change in particles’ sur-
face charge. 
In vitro effects of FNP on the induction of cellular 
antioxidative capacity, actually on the increased activity 
of enzymes of the antioxidative system in the cells 
exposed to oxidative stress, are cell type- and dose- 
-dependent [9]. Results showed that FNP did not 
induce genotoxic effect, on the contrary antigenotoxic 
effects of FNP were confirmed in the experiment done 
on MMC-damaged CHO-K1 cells in concentration of 
11.0–221.6 µM [8]. 
Our present investigation has shown that FNP in 
both examined concentrations moderates the activities 
of oxidative enzymes SOD and GR in comparison to the 
control, which implies that it undoubtedly enters the 
cells and participates in cell metabolism (Fig. 3). This 
mild change in enzyme activity does not affect the 
survival of cells. 
Possible mechanisms responsible for the increased 
activity of SOD in CHO-K1 cells treated with FNP may be 
explained by the fact that fullerenol acts as NO-scav-
enger, which prevents superoxide consumption in the 
reaction of peroxynitrite anion formation, simultane-
ously increasing O2– concentration and SOD activity as a 
consequence of superoxide excess [9,28]. 
Depending on the applied dose, the activity of enz-
yme GR was both, increased and reduced. The increase 
in activity of GR indicates the reduced cellular milieu 
that enables cells to efficiently scavenge free radicals, 
formed as a result of FNP participating in cellular meta-
bolism, which can clarify the absence of significant 
influence of FNP on cell survival. Reduced activity of GR 
in a 3-hour experiment with FNP of higher concen-
tration can be explained by inactivation of this enzyme 
due to increased level of free radicals, while results of 
24-hour experiment suggest the compensatory upreg-
ulation of mRNK and reactivation of mentioned enz-
ymes [13]. 
Fullerenol expressed no influence on GST activity, 
since it probably did not participate in detoxification of 
FNP. Furthermore, FNP did not induce formation of 
oxidative damage products to such extent to activate 
GST. Study conducted on the freshwater zebrafish exp-
osed to fullerenol (C60(OH)18–22(OK4)) analyzed oxid-
ative stress responses on fish brain. They also did not 
detect any statistically significant changes in GST acti-
vity or TBARS level [29].  
Application of mitomycin C significantly increases 
the activity of all three enzymes, which presents the 
antioxidative response of cells to the applied agent. 
High activity of SOD in groups pretreated with FNP in 
comparison with the group treated only with MMC 
could be explained by the fact that fullerenol nano-
particles already act as NO-scavenger which concomi-
B.U. SRDJENOVIC et al.: FULLERENOL NANOPARTICLES IN CELL CULTURE MEDIUM Hem. ind. 69  (4) 425–431 (2015) 
 
429 
tantly increases the O2– concentration and SOD activity. 
Addition of MMC leads to more superoxide production 
and additional influence on the balance between NO 
and O2– in cells, and consequently high SOD activity. 
Pretreatment with the lower concentration of FNP 
notably increases the activity of GR even in comparison 
to mitomycin C. This may happen because FNP in such 
a low concentration does not exhibit potent antioxi-
dative potential, where 24 h after pretreatment the 
activity of this enzyme was yet to reach the control 
level, but still was statistically significantly lower than 
the values in MMC groups. Survival rate of pretreated 
cells was significantly higher in comparison to those 
treated only with MMC, which confirms the protective 
properties of FNP in the range of used concentrations 
in MMC-damaged CHO-K1 cells [8]. 
In acute phase, the higher concentration of FNP 
completely neutralizes the consequences of MMC 
treatment and normalizes the activity of GR, which was 
reflected also on the survival percentage of the cells 
(101.74%). Although the activity of GR after 24 h was 
increased in comparison to control, the survival rate 
was significantly higher than survival rate in MMC 
treated group. The results of GST activity also point out 
the protective effects of FNP since pretreatment with 
FNP significantly neutralizes the influence of MMC on 
the activity of this enzyme. These findings are in 
accordance with the study conducted A549 cells where 
pretreatment with C60(OH)24 attenuated hydrogen per-
oxide-induced apoptotic cell death by induction of 
phase II detoxifying enzymes [30]. 
As previous works concluded, polyhydroxylated ful-
lerenes, as strong antioxidants, influence the cellular 
redox state and thus could reduce cell proliferation, 
which could be exploited for the use of fullerenol as a 
cytoprotective agent [4,31,32].  
CONCLUSION 
In summary, the present results demonstrate that 
polyanion fullerenol nanoparticles reduce mitomycin C- 
-induced oxidative stress in dose- and time-dependent 
manner, and therefore possess beneficial effects on 
preventing drug toxicity in CHO-K1 cells. Applied alone, 
fullerenol nanoparticles influence the cell metabolism 
moderately and not in such a manner to induce any 
severe irreversible changes that would consequently 
lead to the cell death. 
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RASPODELA FULERENOLSKIH NANOČESTICA PO VELIČINI U ĆELIJSKOM MEDIJUMU I NJIHOV UTICAJ NA 
ANTIOKSIDATIVNE ENZIME U OVARIJALNIM ĆELIJAMA KINESKOG HRČKA 
Branislava U. Srdjenovic1, Marija N. Slavić2, Karmen M. Stankov3, Nebojša V. Kladar1, Danica S. Jović4, Mariana N. 
Seke5, Višnja V. Bogdanović6 
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(Naučni rad) 
Zahvaljujući širokoj biološkoj aktivnosti, npr. citoprotektivnom i antiksidativ-
nom svojstvu, fulerenol ima značajnu ulogu u biomedicinskim istraživanjima, na
šta ukazuju i rezultati brojnih istraživanja. Cilj ovog istraživanja je bio merenje zeta
potencijala i raspodele fulerenol nanočestica u medijumu RPMI 1640 + 10% FBS
(Fetal Bovine Serum), kao i ispitivanje uticaja fulerenola na preživljavanje ćelija i
aktivnost tri antioksidativna enzima: superoksid-dismutaze, glutation-reduktaze i 
glutation-S-transferaze, u mitomicinom C tretiranoj ćelijskoj liniji. Istraživanje je
obavljeno na ćelijama jajnika kineskog hrčka CHO-K1 (Chinese Hamster Ovary 
cells) koristeći DET test (Due Exclusion Test) za brojanje ćelija, kao i set spektro-
fotometrijskih metoda za određivanje antioksidativne aktivnosti. Ćelije su pre tret-
mana mitomicinom C tretirane fulerenolom u dve različite koncentracije, a potom
inkubirane i analizirane nakon 3 i 24 h. Dodavanje fulerenolskih nanočestica u
medijum sa 10% FBS nije izazvalo promene u raspodeli veličina čestica po broju ili
zapremini, dok se vrednost zeta potencijala medijuma (ζ) promenila sa –3,6 na
–7,9 mV. Fulerenol ispoljava protektivni efekat na ćelije CHO-K1 koje su tretirane 
mitomicinom C. Mitomicin C povećava aktivnost sva tri ispitana enzima, dok sam
fulerenol u veoma maloj meri utiče na aktivnost pomenutih enzima. Pretretman
sa fulerenolom smanjuje stres indukovan mitomicinom C po vremenski i dozno 
zavisnom obrascu. Naše istraživanje potvrđuje da nanočestice fulerenola utiču na
redoks stanje i enzimsku aktivnost ispitivane ćelijske linije, što ukazuje na to da
mogu sniziti nivo ćelijske proliferacije i naći primenu kao citoprotektivni agens.
  Ključne reči: Fulerenol • Mitomicin C •
Antioksidativni enzimi • CHO K1 ćelijska 
linija 
 
